OneMedNet Announces iRWD Customer Data License Agreement With Leading U.S.-Based Global Clinical Trial Design And Software Company; Provides Regulatory-Grade Real World Data Including EHRs, Lab Results, And Medical Imaging

6/14/24 8:45:45 AM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Get the next $ONMD alert in real time by email

Get the next $ONMD alert in real time by email

Crush Q1 2026 with the Best AI Superconnector

Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

AI-Powered Inbox

Context-aware email replies

Strategic Decision Support

Get Started with Standout.work

Recent Analyst Ratings for
$ONMD

Date	Price Target	Rating	Analyst

More analyst ratings

$ONMD
Press Releases

Fastest customizable press release news feed in the world

View All

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

MINNEAPOLIS, Feb. 27, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) (the "OneMedNet," the "Company," "we," "us" or "our"), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced the next phase of commercial launch with its RWD Platform powered by Palantir Foundry. Following the successful November 10, 2025, demonstration of live feeds, subscription access, and AI-driven search at major tradeshows, the Company is actively converting customer evaluations into commercial subscriptions. Early results highlight superior performance, speed and analytical depth, reinforcing OneMedNet's position for life sciences and healthcare organizations generati

2/27/26 8:50:00 AM ET

$ONMD

Biotechnology: Commercial Physical & Biological Resarch

Health Care

OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers

MINNEAPOLIS, Feb. 26, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic partnership with ViuHealth, a digital health company specializing in autoimmune disease populations. This partnership expands OneMedNet's autoimmune clinical ontology, to the OneMedNet iRWD™ platform—powered by Palantir Foundry—further increasing the scale, diversity, and longitudinal depth of its regulatory-grade Real-World Data. Under the agreement, ViuHealth will provide ongoing, longitudinal autoimmune disease data, strengthening OneMedNet's portfolio of high-value specialty datasets and supporting resea

2/26/26 8:40:00 AM ET

$ONMD

Biotechnology: Commercial Physical & Biological Resarch

Health Care

OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers

MINNEAPOLIS, Feb. 24, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced a strategic data licensing agreement with Risorius Co., Ltd., a neurotechnology company developing EEG-based digital biomarkers and AI-powered research platforms for central nervous system (CNS) indications across neurology, psychiatry, and sleep. This new relationship supports OneMedNet's continued focus on expanding its base of subscription contracts, adding multi-year agreements that represent millions of dollars in incremental recurring revenue. The agreement was executed in record time following the companies' init

2/24/26 8:53:10 AM ET

$ONMD

Biotechnology: Commercial Physical & Biological Resarch

Health Care

$ONMD
Leadership Updates

Live Leadership Updates

View All

Dr. Kenneth Alleyne Joins OneMedNet Board of Directors

MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet"), the leading Real World Data platform powered by AI-driven de-identification, announces the appointment of Dr. Kenneth Alleyne to its Board of Directors. A board-certified orthopedic surgeon specializing in sports medicine, Dr. Alleyne will assume the role of Chair of the Audit Committee, bringing extensive expertise in healthcare, insurance, investment, and corporate governance to the organization. Dr. Alleyne is the managing partner of HartHaven Partners, a healthcare consulting firm supporting private equity and venture capital firms. He co-founded NextLevel Health Partners and Zing Health

3/3/25 8:35:00 AM ET

$ONMD

Biotechnology: Commercial Physical & Biological Resarch

Health Care

OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development

MINNEAPOLIS, Dec. 02, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), a Real-World Data (RWD) platform — has announced its collaboration with Bayer's AI Innovation Platform (AIIP). By joining AIIP, the partnership aims to empower the developer teams of healthcare organizations and startups in building scalable and compliant AI-powered medical imaging software products. "We are thrilled to join forces with Bayer's AI Innovation Platform," said Aaron Green, CEO & President of OneMedNet. "This collaboration allows us to combine our regulatory-grade real-world data platform, which aggregates data from our provider network of over 1,400 healthcare

12/2/24 8:30:00 AM ET

$ONMD

Biotechnology: Commercial Physical & Biological Resarch

Health Care

OneMedNet appoints new CFO

MINNEAPOLIS, Sept. 10, 2024 (GLOBE NEWSWIRE) -- OneMedNet Corporation (NASDAQ:ONMD) ("OneMedNet" or the "Company"), the leading curator of regulatory-grade Real World Data (RWD), has announced that Bob Golden has joined the OneMedNet Executive Team as Chief Financial Officer spearheading all aspects of the company's financial and accounting operations while continuing to serve as a member of the Board of Directors. Mr. Golden is a Certified Public Accountant with more than 40 years of experience. Mr. Golden has served as the Managing Partner of Cohen, Bender & Golden LLP since 2015, where he provides consulting, accounting and tax services to middle market businesses and owners. Mr. Golde

9/10/24 8:45:00 AM ET

$ONMD

Biotechnology: Commercial Physical & Biological Resarch

Health Care

OneMedNet Announces iRWD Customer Data License Agreement With Leading U.S.-Based Global Clinical Trial Design And Software Company; Provides Regulatory-Grade Real World Data Including EHRs, Lab Results, And Medical Imaging

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ONMD

OneMedNet Announces iRWD Customer Data License Agreement With Leading U.S.-Based Global Clinical Trial Design And Software Company; Provides Regulatory-Grade Real World Data Including EHRs, Lab Results, And Medical Imaging

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ONMD

$ONMD
Press Releases

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers

OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers

$ONMD
Insider Trading

Chief Executive Officer Green Aaron sold $218,625 worth of shares (126,322 units at $1.73), decreasing direct ownership by 7% to 1,804,103 units (SEC Form 4)

Chief Medical Officer Yu Jeffrey converted options into 2,307,549 shares, bought $959,586 worth of shares (2,010,479 units at $0.48) and was granted 245,000 shares, increasing direct ownership by 165% to 7,326,223 units (SEC Form 4)

Chief Medical Officer Yu Jeffrey bought $8,929 worth of shares (9,540 units at $0.94) and was granted 230,769 shares, increasing direct ownership by 10% to 2,763,195 units (SEC Form 4)

$ONMD
Insider Purchases

Chief Medical Officer Yu Jeffrey converted options into 2,307,549 shares, bought $959,586 worth of shares (2,010,479 units at $0.48) and was granted 245,000 shares, increasing direct ownership by 165% to 7,326,223 units (SEC Form 4)

Chief Medical Officer Yu Jeffrey bought $8,929 worth of shares (9,540 units at $0.94) and was granted 230,769 shares, increasing direct ownership by 10% to 2,763,195 units (SEC Form 4)

Director Casaburi Eric bought $39,262 worth of shares (20,475 units at $1.92) and was granted 90,000 shares (SEC Form 4)

$ONMD
SEC Filings

OneMedNet Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events

Amendment: SEC Form SCHEDULE 13G/A filed by OneMedNet Corp

SEC Form 424B3 filed by OneMedNet Corp

$ONMD
Leadership Updates

Dr. Kenneth Alleyne Joins OneMedNet Board of Directors

OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development

OneMedNet appoints new CFO

$ONMD
Financials

OneMedNet Reports 815% Bookings Increase and 4.5X increase in Inbound Demand

OneMedNet Reports 80% Reduction in Debt Enabling Focus On Growth

$ONMD
Large Ownership Changes

SEC Form SC 13G filed by OneMedNet Corp

SEC Form SC 13G filed by OneMedNet Corp

SEC Form SC 13G filed by OneMedNet Corp

OneMedNet Announces iRWD Customer Data License Agreement With Leading U.S.-Based Global Clinical Trial Design And Software Company; Provides Regulatory-Grade Real World Data Including EHRs, Lab Results, And Medical Imaging

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $ONMD

OneMedNet Announces iRWD Customer Data License Agreement With Leading U.S.-Based Global Clinical Trial Design And Software Company; Provides Regulatory-Grade Real World Data Including EHRs, Lab Results, And Medical Imaging

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $ONMD

$ONMD Press Releases

OneMedNet Announces Next Phase of Commercial Launch with its Real-World Data (RWD) Platform powered by Palantir Foundry

OneMedNet Partners with ViuHealth to Enhance Autoimmune Dataset Scale, Accelerating Recurring Revenue from Life Sciences and AI Customers

OneMedNet Announces Strategic Neuro Data Partnership with Risorius to Advance EEG-Based Digital Biomarkers

$ONMD Insider Trading

Chief Executive Officer Green Aaron sold $218,625 worth of shares (126,322 units at $1.73), decreasing direct ownership by 7% to 1,804,103 units (SEC Form 4)

Chief Medical Officer Yu Jeffrey converted options into 2,307,549 shares, bought $959,586 worth of shares (2,010,479 units at $0.48) and was granted 245,000 shares, increasing direct ownership by 165% to 7,326,223 units (SEC Form 4)

Chief Medical Officer Yu Jeffrey bought $8,929 worth of shares (9,540 units at $0.94) and was granted 230,769 shares, increasing direct ownership by 10% to 2,763,195 units (SEC Form 4)

$ONMD Insider Purchases

Chief Medical Officer Yu Jeffrey converted options into 2,307,549 shares, bought $959,586 worth of shares (2,010,479 units at $0.48) and was granted 245,000 shares, increasing direct ownership by 165% to 7,326,223 units (SEC Form 4)

Chief Medical Officer Yu Jeffrey bought $8,929 worth of shares (9,540 units at $0.94) and was granted 230,769 shares, increasing direct ownership by 10% to 2,763,195 units (SEC Form 4)

Director Casaburi Eric bought $39,262 worth of shares (20,475 units at $1.92) and was granted 90,000 shares (SEC Form 4)

$ONMD SEC Filings

OneMedNet Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events

Amendment: SEC Form SCHEDULE 13G/A filed by OneMedNet Corp

SEC Form 424B3 filed by OneMedNet Corp

$ONMD Leadership Updates

Dr. Kenneth Alleyne Joins OneMedNet Board of Directors

OneMedNet Announces Exciting New Collaboration with Bayer's AI Innovation Platform to Help Accelerate Healthcare AI Development

OneMedNet appoints new CFO

$ONMD Financials

OneMedNet Reports 815% Bookings Increase and 4.5X increase in Inbound Demand

OneMedNet Reports 80% Reduction in Debt Enabling Focus On Growth

$ONMD Large Ownership Changes

SEC Form SC 13G filed by OneMedNet Corp

SEC Form SC 13G filed by OneMedNet Corp

SEC Form SC 13G filed by OneMedNet Corp

Recent Analyst Ratings for
$ONMD

Recent Analyst Ratings for
$ONMD

$ONMD
Press Releases

$ONMD
Insider Trading

$ONMD
Insider Purchases

$ONMD
SEC Filings

$ONMD
Leadership Updates

$ONMD
Financials

$ONMD
Large Ownership Changes